CRIS Current Research Information System

LEONI, ILARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.009
EU - Europa 578
NA - Nord America 577
AF - Africa 52
Continente sconosciuto - Info sul continente non disponibili 41
SA - Sud America 38
Totale 2.295
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 548
IT - Italia 382
VN - Vietnam 365
CN - Cina 187
SG - Singapore 166
HK - Hong Kong 78
BD - Bangladesh 67
FR - Francia 41
NL - Olanda 38
KR - Corea 30
BR - Brasile 29
DE - Germania 28
JP - Giappone 26
IN - India 22
ZA - Sudafrica 21
CA - Canada 20
FI - Finlandia 14
GB - Regno Unito 14
TH - Thailandia 14
PH - Filippine 12
IE - Irlanda 11
CI - Costa d'Avorio 10
SC - Seychelles 10
PK - Pakistan 9
PL - Polonia 9
SE - Svezia 8
AT - Austria 7
CH - Svizzera 6
RU - Federazione Russa 6
TR - Turchia 6
TW - Taiwan 6
ID - Indonesia 5
MX - Messico 5
AR - Argentina 3
EC - Ecuador 3
ES - Italia 3
BG - Bulgaria 2
CR - Costa Rica 2
CZ - Repubblica Ceca 2
DZ - Algeria 2
EG - Egitto 2
GH - Ghana 2
IQ - Iraq 2
IR - Iran 2
JO - Giordania 2
LT - Lituania 2
TN - Tunisia 2
UZ - Uzbekistan 2
AE - Emirati Arabi Uniti 1
BE - Belgio 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
GE - Georgia 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MM - Myanmar 1
MY - Malesia 1
OM - Oman 1
PY - Paraguay 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
Totale 2.254
Salva come PNG Salva come JPEG
Città #
Singapore 131
Bologna 110
Ho Chi Minh City 94
Hanoi 86
San Jose 77
Ashburn 72
Hefei 67
Hong Kong 67
Council Bluffs 45
Boardman 37
Milan 36
Dallas 29
New York 27
Seoul 27
Los Angeles 25
Lauterbourg 23
Da Nang 22
Johannesburg 20
Tokyo 19
Haiphong 15
Helsinki 14
Santa Clara 14
Amsterdam 12
Chicago 12
Dublin 11
Modena 11
Rome 11
Abidjan 10
Munich 10
Parma 10
Florence 9
Beijing 8
Imola 8
Frankfurt am Main 7
Hải Dương 7
Rimini 7
São Paulo 7
Treviso 7
Bengaluru 6
Philadelphia 6
Phoenix 6
Polinago 6
Vienna 6
Warsaw 6
Bangkok 5
Bern 5
Buffalo 5
Genoa 5
Houston 5
Long Xuyen 5
Montreal 5
Naples 5
Nha Trang 5
Palermo 5
Reggio Emilia 5
San Diego 5
Shenzhen 5
Brooklyn 4
Cao Lanh 4
Katy 4
Lahore 4
Lissone 4
Orem 4
Redondo Beach 4
Shanghai 4
Toronto 4
Tân Tiến 4
Bắc Giang 3
Can Tho 3
Castel Maggiore 3
Charlotte 3
City of London 3
Düsseldorf 3
Figino 3
Jakarta 3
Lanett 3
L’Aquila 3
Mexico City 3
Monticello 3
Mumbai 3
Paris 3
Peshawar 3
Phuket 3
Secaucus 3
Thái Bình 3
Venice 3
Điện Bàn 3
Accra 2
Alexandria 2
Amman 2
Austell 2
Barnet 2
Beverwijk 2
Birmingham 2
Biên Hòa 2
Cache 2
Cairo 2
Castel Bolognese 2
Castelcucco 2
Castelfranco Emilia 2
Totale 1.431
Salva come PNG Salva come JPEG
Nome #
Gut Microbiome Modulation in Hepatocellular Carcinoma: Preventive Role in NAFLD/NASH Progression and Potential Applications in Immunotherapy-Based Strategies 293
MiR-494 induces metabolic changes through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 245
MiR-22/GLUT1 Axis Induces Metabolic Reprogramming and Sorafenib Resistance in Hepatocellular Carcinoma 232
Noncoding RNAs in Hepatocellular Carcinoma: Potential Applications in Combined Therapeutic Strategies and Promising Candidates of Treatment Response 189
Hepatic cancer stem cells: Molecular mechanisms, therapeutic implications, and circulating biomarkers 176
Mir-30e-3p/CXCL3 axis is involved in sorafenib resistance of hepatocellular carcinoma through the modulation of the tumor immune microenvironment 118
Gut microbiome alterations and lenvatinib resistance in hepatocellular carcinoma: the role of Akkermansia muciniphila postbiotics in treatment enhancement 109
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated hepatocellular carcinoma patients. 94
miR-30e-3p/CXCL3 axis predicts early tumor escape in hepatocellular carcinoma patients undergoing sorafenib treatment 82
MiR-22-3p targets the G2/M checkpoint inhibitor Wee1 and represents a possible biomarker of TACE response in hepatocellular carcinoma 80
Towards precision medicine: a preliminary collection of patient-derived organoids for the screening of personalised therapies in hepatocellular carcinoma 78
MiR-22 downregulation activates HIF-1A pathway and induces tumour progression, metabolic reprogramming and sorafenib resistance in hepatocellular carcinoma 78
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 77
The tumour suppressor miR-22 induces metabolic reprogramming through GLUT1 targeting and represents a possible biomarker of Sorafenib response in Hepatocellular Carcinoma 74
CXCL3 is a target of miR-30e-3p and predicts tumor escape in sorafenib-treated HCC patients. 72
miR-30e-3p/CXCL3 axis predicts early tumor escape in sorafenib-treated HCC patients. 70
MiR-494 induces metabolic reprogramming through G6pc targeting and modulates sorafenib response in hepatocellular carcinoma 64
MiR-22 regulates HIF-1A pathway and tumor progression and represents a possible biomarker of sorafenib response in hepatocellular carcinoma 61
MiR-30e-3p plays a dual role in hepatocellular carcinoma and predicts tumour escape to sorafenib Treatment 56
Circulating miR-22 Early Predicts TACE Non-Response and Targets WEE1 in Hepatocellular Carcinoma 47
Totale 2.295
Salva come PNG Salva come JPEG
Categoria #
all - tutte 5.024
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.024
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202223 0 0 0 0 0 0 0 9 1 2 10 1
2022/202330 0 1 1 1 0 2 3 1 7 0 5 9
2023/202479 7 8 2 11 6 10 3 9 2 7 4 10
2024/2025199 13 16 9 11 9 9 9 5 6 36 30 46
2025/20261.821 95 102 93 67 49 141 260 132 420 102 125 235
2026/2027143 86 57 0 0 0 0 0 0 0 0 0 0
Totale 2.295